PPARA and inflammatory bowel disease: To conclude, the key findings in this study elicited that MSCs‐EVs could carry miR‐378a‐3p to inhibit the transcription factor GATA2, which can downregulate the expression of AQP4 and block PPAR‐α signalling pathway, thus inhibiting the occurrence of IBD (Figure 7).